TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Active Biotech AB (publ)
Closing information (x1000 DKK)
Closing information | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Turnover | 0 | 0 | 4,984 |
Financial expenses | 358 | 42 | 114 |
Earnings before taxes | -39,006 | -36,229 | -23,899 |
EBITDA | -38,681 | -36,198 | -23,944 |
Total assets | 34,083 | 41,304 | 23,832 |
Current assets | 29,482 | 40,616 | 22,445 |
Current liabilities | 8,060 | 7,202 | 6,932 |
Equity capital | 23,061 | 33,938 | 16,389 |
- share capital | 914 | 819 | 556 |
Employees (average) | 9 | 8 | 10 |
Financial ratios
Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Solvency | 67.7% | 82.2% | 68.8% |
Turnover per employee | 0 | 0 | 498 |
Profit as a percentage of turnover | -479.5% | ||
Return on assets (ROA) | -113.4% | -87.6% | -99.8% |
Current ratio | 365.8% | 564.0% | 323.8% |
Return on equity (ROE) | -169.1% | -106.8% | -145.8% |
Change turnover | 0 | -4,890 | -1,260 |
Change turnover % | -100% | -20% | |
Chg. No. of employees | 1 | -2 | -2 |
Chg. No. of employees % | 13% | -20% | -17% |
Total value of public sale
Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.